Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Hepatic Malignant Mixed Tumour – Symptoms, Treatment & Support

What Is Hepatic Malignant Mixed Tumour? Hepatic malignant mixed tumour is a rare type of liver cancer characterized by the presence of both epithelial and mesenchymal components. This means the tumour contains cells that are characteristic of both glandular tissues...

Nasopharyngeal Cancer, Undifferentiated – Symptoms, Treatment & Support

What Is Nasopharyngeal Cancer, Undifferentiated? Nasopharyngeal cancer, undifferentiated, refers to a type of cancer that arises in the nasopharynx, the upper part of the throat behind the nose. This cancer is characterized by cells that do not resemble normal cells...

Papillary Serous Adenocarcinoma of the Fallopian Tube – Symptoms, Treatment & Support

What is Papillary Serous Adenocarcinoma of the Fallopian Tube? Papillary serous adenocarcinoma of the fallopian tube is a rare and aggressive form of cancer that originates in the fallopian tubes, which are part of the female reproductive system. This type of cancer...

Haemangioendothelioma of the Liver – Symptoms, Treatment & Support

What Is Haemangioendothelioma of the Liver? Haemangioendothelioma of the liver is a rare vascular tumour that arises from the endothelial cells lining the blood vessels of the liver. This tumour can range from benign to low-grade malignant and is considered less...

Renal Cell Carcinoma – Clear Cell – Symptoms, Treatment & Support

What Is Renal Cell Carcinoma – Clear Cell? Renal cell carcinoma – clear cell (ccRCC) is the most common type of kidney cancer in adults, representing about 70-80% of all renal cell carcinomas. It’s named for the appearance of the cancer cells under a...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter